Home / Stocks / VRXA

VRXA insider trading

Veraxa Biotech AG - Post de-SPAC — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
2
Bought · 24 mo
$83k
Buys · last 90 days
2 · $83k
Most recent buy
2026-08-31

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-08-31Antz Christoph Rudiger
Chief Executive Officer
Bought5,000$1.53$8k
2026-08-31Baumann Oliver Rolf
Director
Bought50,000$1.50$75k

Most active insider buyers

InsiderRoleBuysTotal bought
Baumann Oliver RolfDirector1$75k
Antz Christoph RudigerChief Executive Officer1$8k

See VRXA on the chart

Every insider buy and sell for VRXA plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.